Equities research analysts expect Vitamin Shoppe Inc (NYSE:VSI) to report $262.27 million in sales for the current quarter, according to Zacks. Two analysts have issued estimates for Vitamin Shoppe’s earnings. The lowest sales estimate is $261.64 million and the highest is $262.89 million. Vitamin Shoppe posted sales of $304.87 million during the same quarter last year, which would indicate a negative year over year growth rate of 14%. The business is expected to announce its next earnings results before the market opens on Tuesday, February 27th.
According to Zacks, analysts expect that Vitamin Shoppe will report full year sales of $262.27 million for the current year, with estimates ranging from $1.17 billion to $1.19 billion. For the next fiscal year, analysts expect that the firm will post sales of $1.16 billion per share, with estimates ranging from $1.14 billion to $1.17 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Vitamin Shoppe.
VSI has been the subject of several analyst reports. Zacks Investment Research raised Vitamin Shoppe from a “sell” rating to a “hold” rating in a research note on Wednesday, October 25th. Barclays lowered their price objective on Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating for the company in a research note on Thursday, November 9th. ValuEngine lowered Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Finally, Morgan Stanley decreased their price target on Vitamin Shoppe from $7.50 to $4.00 and set an “equal weight” rating for the company in a research note on Thursday, November 9th. Three analysts have rated the stock with a sell rating and six have assigned a hold rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $5.00.
In other news, major shareholder Vintage Capital Management Llc acquired 133,804 shares of Vitamin Shoppe stock in a transaction on Tuesday, January 2nd. The shares were bought at an average cost of $4.28 per share, for a total transaction of $572,681.12. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, major shareholder Shah Capital Management acquired 300,000 shares of Vitamin Shoppe stock in a transaction on Monday, February 5th. The shares were purchased at an average price of $3.83 per share, for a total transaction of $1,149,000.00. The disclosure for this purchase can be found here. Insiders have purchased a total of 1,000,639 shares of company stock valued at $4,387,647 over the last three months. 1.07% of the stock is owned by corporate insiders.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Voya Investment Management LLC increased its holdings in Vitamin Shoppe by 7.5% during the 2nd quarter. Voya Investment Management LLC now owns 34,810 shares of the specialty retailer’s stock worth $406,000 after purchasing an additional 2,414 shares during the period. Dynamic Technology Lab Private Ltd increased its holdings in Vitamin Shoppe by 72.7% during the 2nd quarter. Dynamic Technology Lab Private Ltd now owns 17,761 shares of the specialty retailer’s stock worth $207,000 after purchasing an additional 7,478 shares during the period. UBS Asset Management Americas Inc. increased its holdings in Vitamin Shoppe by 17,041.4% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 11,999 shares of the specialty retailer’s stock worth $140,000 after purchasing an additional 11,929 shares during the period. Pinebridge Investments L.P. increased its holdings in Vitamin Shoppe by 28.3% during the 4th quarter. Pinebridge Investments L.P. now owns 63,860 shares of the specialty retailer’s stock worth $281,000 after purchasing an additional 14,079 shares during the period. Finally, Nationwide Fund Advisors increased its holdings in Vitamin Shoppe by 84.3% during the 2nd quarter. Nationwide Fund Advisors now owns 31,662 shares of the specialty retailer’s stock worth $369,000 after purchasing an additional 14,478 shares during the period. Institutional investors own 99.86% of the company’s stock.
WARNING: This story was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2018/02/14/262-27-million-in-sales-expected-for-vitamin-shoppe-inc-vsi-this-quarter.html.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.